Skip to main content
. 2020 Aug 11;2020(8):CD008016. doi: 10.1002/14651858.CD008016.pub3

EUCTR2005‐005499‐34.

Methods Allocation: randomised.
Location: multi‐centre.
Participants Diagnosis: stable schizophrenia.
Interventions 1, Bifeprunox (not marketed drug)
2. Quetiapine
3. Placebo
Outcomes Standard efficacy, safety and tolerability measures.
Notes Prematurely ended, no data available. We were not able to find further information.